Epigenetic code during mycobacterial infections: therapeutic implications for tuberculosis
Authors:
Open Access
- 28 August 2021
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 289 (14) , 4172-4191
Abstract
Epigenetics involves changing the gene function without any change in the sequence of the genes. In the case of tuberculosis (TB) infections, the bacilli, Mycobacterium tuberculosis (M.tb), uses epigenetics as a tool to protect itself from the host immune system. TB is a deadly disease‐causing maximum death per year due to a single infectious agent. In the case of TB, there is an urgent need for novel host‐directed therapies which can effectively target the survival and long‐term persistence of the bacteria without developing drug resistance in the bacterial strains while also reducing the duration and toxicity associated with the mainstream anti‐TB drugs. Recent studies have suggested that TB infection has a significant effect on the host epigenome thereby manipulating the host immune response in the favor of the pathogen. M.tb alters the activation status of key genes involved in the immune response against TB to promote its survival and subvert the antibacterial strategies of the host. These changes are reversible and can be exploited to design very efficient host‐directed therapies to fight against TB. This review has been written with the purpose of discussing the role of epigenetic changes in TB pathogenesis and the therapeutic approaches involving epigenetics, which can be utilized for targeting the pathogen.Keywords
This publication has 126 references indexed in Scilit:
- Inhibition of Nuclear Factor-Kappa B Activation Decreases Survival of Mycobacterium tuberculosis in Human MacrophagesPLOS ONE, 2013
- Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host ImmunityJournal of Biological Chemistry, 2013
- Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytesProceedings of the National Academy of Sciences, 2012
- Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7Proceedings of the National Academy of Sciences, 2012
- MicroRNA-21 targets the vitamin D–dependent antimicrobial pathway in leprosyNature Medicine, 2012
- Mycobacterium tuberculosislipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125bProceedings of the National Academy of Sciences, 2011
- Dissecting the diverse functions of the metastasis suppressor CD82/KAI1FEBS Letters, 2011
- The widespread regulation of microRNA biogenesis, function and decayNature Reviews Genetics, 2010
- CpG islands – ‘A rough guide’FEBS Letters, 2009
- Dynamic protein methylation in chromatin biologyCellular and Molecular Life Sciences, 2008